Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
26/01/2021 - 7 minutes
News and Trends
GSK Acne Deal Heralds Growing Interest in Skin Microbiome
This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to…
15/01/2021 - 4 minutes
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
22/12/2020 - 5 minutes
Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
21/12/2020 - 5 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
17/12/2020 - 6 minutes
Will Europe Follow Singapore in Approving Cultured Meat?
Singapore is the first country to grant approval to meat grown from animal cells, known…
14/12/2020 - 5 minutes
The Manufacturing Challenge to Meet Covid-19 Vaccine Demands
Companies developing vaccines, drugs, and diagnostics for Covid-19 are being forced to scale up manufacturing…
09/12/2020 - 5 minutes
Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures
In spite of recent failures of clinical trials from others in the field, Swiss company…
07/12/2020 - 3 minutes
EU Launches Pharma Strategy, Raising Both Hopes and Questions
The public's response has been cautious after the European Union unveiled a pharmaceutical strategy last…
04/12/2020 - 6 minutes
uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy
Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer…
27/11/2020 - 5 minutes
AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III
A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70%…
26/11/2020 - 4 minutes
SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’
The newly founded SynOx has become the latest startup to attack solid tumors via their…
23/11/2020 - 4 minutes
